Adrenergic blocking agents

A &beta1-adrenergic receptor antagonist (Kis = 1.14 and 48.7 &microM for &beta1 and &beta2, respectively) has applications in cardiology and vascular disease.

A &beta1-adrenergic receptor antagonist (Kis = 1.14 and 48.7 &microM for &beta1 and &beta2, respectively) has applications in cardiology and vascular disease.

A &beta1-adrenergic receptor antagonist (Kis = 1.14 and 48.7 &microM for &beta1 and &beta2, respectively) has applications in cardiology and vascular disease.

A &beta1-adrenergic receptor antagonist (Kis = 1.14 and 48.7 &microM for &beta1 and &beta2, respectively) has applications in cardiology and vascular disease.

(RS)-Butyryltimolol is the racemate of Butyryltimolol. Butyryltimolol, an effective proagent of Timolol, improves the corneal penetration of Timolol Butyryltimolol is a β-adrenergic blocker .In VitroButyryltimolol, a prodrug of Timolol, is equally

(RS)-Butyryltimolol is the racemate of Butyryltimolol. Butyryltimolol, an effective proagent of Timolol, improves the corneal penetration of Timolol Butyryltimolol is a β-adrenergic blocker .In VitroButyryltimolol, a prodrug of Timolol, is equally

(RS)-Butyryltimolol is the racemate of Butyryltimolol. Butyryltimolol, an effective proagent of Timolol, improves the corneal penetration of Timolol Butyryltimolol is a β-adrenergic blocker .In VitroButyryltimolol, a prodrug of Timolol, is equally

(RS)-Butyryltimolol is the racemate of Butyryltimolol. Butyryltimolol, an effective proagent of Timolol, improves the corneal penetration of Timolol Butyryltimolol is a β-adrenergic blocker .In VitroButyryltimolol, a prodrug of Timolol, is equally

(RS)-Butyryltimolol is the racemate of Butyryltimolol. Butyryltimolol, an effective proagent of Timolol, improves the corneal penetration of Timolol Butyryltimolol is a β-adrenergic blocker .In VitroButyryltimolol, a prodrug of Timolol, is equally

Application Protein degrader building block ( S , R , S )-VL285 Phenol-PEG 2 -NH 2 hydrochloride enables the synthesis of molecules for targeted protein degradation and PROTAC (proteolysis-targeting chimeras) technology . This conjugate contains a

Application Protein degrader building block ( S , R , S )-VL285 Phenol-PEG 4 -NH 2 hydrochloride enables the synthesis of molecules for targeted protein degradation and PROTAC (proteolysis-targeting chimeras) technology . This conjugate contains a

( S )-(+)-2-Pyrrolidinemethanol, also known as ( S )-(+)-prolinol is a chiral building block that is used for the synthesis of chiral organic compounds. It is also used as a chiral auxiliary in asymmetric synthesis and a chiral ligand in asymmetric